Ex-Drug Company CEO Martin Shkreli to Speak at Harvard - NECN


The latest news from around the state

Ex-Drug Company CEO Martin Shkreli to Speak at Harvard



    Your Summer Guide to Boston Harbor
    FILE - AP
    Pharmaceutical chief Martin Shkreli smiles on Capitol Hill in Washington, Thursday, Feb. 4, 2016, during the House Committee on Oversight and Reform Committee hearing on his former company's decision to raise the price of a lifesaving medicine. Shkreli refused to testify before U.S. lawmakers who excoriated him over severe hikes for a drug sold by a company that he acquired.

    Controversial former pharmaceutical executive Martin Shkreli is set to speak at Harvard while out on bail awaiting his federal securities fraud trial.

    The former CEO of Turing Pharmaceuticals is expected to talk about investing and health care at an event organized by the Harvard Financial Analysts Club. The talk on Wednesday is open to the Harvard community only.

    Shkreli drew sharp criticism after his company purchased the rights to a drug used by AIDS and cancer patients to fight parasitic infections and raised its price from less than $17 to $750 per pill.

    The 33-year-old New York resident is free on $5 million bail pending his federal securities fraud trial in an unrelated case. He has pleaded not guilty. A judge on Thursday approved his request to travel to Massachusetts.

    Get the latest from necn anywhere, anytime

    • Download the App

      Available for IOS and Android